by Dr. Reinhard Hiller | Jul 18, 2013 | Blog, Emerging markets, VC financing
A recent article on Nature’s Trade Secrets Blog1 looked at ways to measure a country’s attractiveness for biotech investment. Specifically, it explored a possible relationship between the 2013 Scientific American’s innovation scorecard data2 and the 2013 edition of a...
by Dr. Reinhard Hiller | Jun 17, 2013 | Blog, Emerging markets, VC financing
A recent paper in Nature Biotechnology (Huggett, 2013) suggests some worrying trends in VC funding in the biotech sector, and a negative impact on start-up financing in the drug and medical device industry in particular. VC financing appears to be at an 8-year low in...
by Dr. Reinhard Hiller | Mar 12, 2013 | Blog, Emerging markets, VC financing
A recent paper in Nature Biotechnology by Chakma, Sammut & Agrawal (2013) (1) investigates the state of venture capital financing in emerging markets. The authors took a closer look at the state of VC affairs in the life sciences sectors of Brazil China, India,...
Recent Comments